CLINICAL_TRIALS
trial_result
· 2025-02-12
Clinical Trial Update: At-Risk for Type 1 Diabetes Extension Study (TN-10 Extension) [Phase 2]
Summary
Results posted for the TN-10 Extension, a Phase 2 trial in individuals at risk for Type 1 diabetes; the study is completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Provention Bio, a Sanofi Company | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: COMPLETED | Results posted: 2025-02-12